Modern Occupational Diseases Diagnosis Epidemiology Management and Prevention 1st Edition by Ki Moon Bang ISBN 9789815049145 9815049143

Modern Occupational Diseases Diagnosis Epidemiology Management and Prevention 1st Edition by Ki Moon Bang – Ebook PDF Instant Download/Delivery: 9789815049145 ,9815049143
Full download Modern Occupational Diseases Diagnosis Epidemiology Management and Prevention 1st Edition after payment

Product details:

ISBN 10: 9815049143
ISBN 13: 9789815049145
Author: Ki Moon Bang

Modern Occupational Diseases Diagnosis Epidemiology Management and Prevention 1st Edition Table of contents:

1. Occupational Disease in the 21st Century: COVID-19, Climate Change, and the Fourth Industrial Revolu
2. Kelly M. Hager1, Brian Linde1 and Carrie A. Redlich1,*
3. INTRODUCTION
4. THE CHANGING ECONOMY/CHANGING STRUCTURE OF WORK
5. Non-standard Work and Precarious Employment
6. Work Organization
7. CONTRIBUTION OF WORK TO OTHER HEALTH DISPARITIES
8. COVID-19 AS AN EXAMPLE OF AN EMERGING OCCUPATIONAL DISEASE AND WORK HEALTH DISPARITIES
9. Effects on Workers
10. Health Disparities
11. Other Health Effects
12. Protections Looking to the Future
13. CLIMATE CHANGE
14. Climate Change and Human Health
15. Heat Stress
16. Air Quality
17. Increase in Natural Disasters and Resurgence of Zoonotic Diseases
18. Future Recommendations
19. HOW TO BETTER PROTECT WORKERS IN THE FUTURE
20. CONSENT FOR PUBLICATION
21. CONFLICT OF INTEREST
22. ACKNOWLEDGEMENT
23. REFERENCES
24. Occupational Epidemiology
25. Ki Moon Bang1,*
26. INTRODUCTION
27. USE OF EPIDEMIOLOGY IN OCCUPATIONAL DISEASE
28. Descriptive Study
29. Analytic Studies
30. Experimental Study
31. TYPE OF STUDIES AND EXAMPLES
32. Cohort Study
33. Example 1. Prospective Cohort Mortality Study
34. Example 2. Prospective Cohort Morbidity Study
35. Case-Control Study
36. Example 1
37. Example 2
38. Example 3
39. Cross-Sectional Study
40. Example 1
41. Example 2
42. Ecologic Study
43. Example
44. Meta-Analysis
45. Example
46. Epidemiologic Surveillance for Occupational Disease
47. Example 1
48. Example 2
49. Molecular Epidemiologic Study
50. Example
51. CONCLUSION
52. CONSENT FOR PUBLICATION
53. CONFLICT OF INTEREST
54. ACKNOWLEDGEMENT
55. REFERENCES
56. Asbestosis
57. Ian Henderson1,*, Daniel H. Sterman1, Robert L. Smith1 and William N. Rom1
58. BACKGROUND
59. BENIGN PARENCHYMAL MANIFESTATIONS
60. Asbestosis
61. Pathology
62. Pathogenesis
63. Epidemiology
64. Clinical, Radiographic, and Physiologic Features
65. Diagnosis and Treatment
66. BENIGN PLEURAL MANIFESTATIONS
67. Pleural Plaques
68. Pathology and Pathogenesis
69. Epidemiology
70. Clinical, Radiographic, and Physiologic Features
71. Diagnosis and Treatment
72. Diffuse Pleural Thickening
73. Pathology and Pathogenesis
74. Clinical, Radiographic, and Physiologic Features
75. Diagnosis and Treatment
76. Rounded Atelectasis
77. Acute Benign Pleural Effusion
78. EFFORTS TO CONTROL ASBESTOS
79. CONSENT FOR PUBLICATION
80. CONFLICT OF INTEREST
81. ACKNOWLEDGEMENT
82. REFERENCES
83. Silicosis
84. David N. Weissman1,* and Robert J. Tallaksen2
85. INTRODUCTION
86. RESPIRABLE CRYSTALLINE SILICA (RCS)
87. EXPOSURES TO RCS
88. PATHOGENESIS OF SILICOSIS
89. EPIDEMIOLOGY OF SILICOSIS
90. RADIOGRAPHIC IMAGING OF SILICOSIS
91. CLINICAL PRESENTATION OF SILICOSIS
92. DIAGNOSIS OF SILICOSIS
93. MANAGEMENT OF SILICOSIS
94. PREVENTION OF SILICOSIS
95. DISCLAIMER
96. CONSENT FOR PUBLICATION
97. CONFLICT OF INTEREST
98. ACKNOWLEDGEMENT
99. REFERENCES
100. Coal Workers Pneumoconiosis
101. Rafia Zulfikar1,* and John E. Parker1
102. INTRODUCTION
103. Historical Background
104. Coal
105. Mining Methods
106. Coal Mine Dust
107. EPIDEMIOLOGY
108. Graph 1:
109. Graph 2:
110. PATHOLOGY AND IMMUNOLOGY
111. CLINICAL FEATURES
112. Radiology
113. Pulmonary Function Test
114. Bronchoalveolar Lavage (BAL)
115. TREATMENT
116. Prevention and Monitoring
117. Lung Transplant
118. Potential role of Antifibrotics
119. SUMMARY
120. CONSENT OF PULICATION
121. CONFLICT OF INTEREST
122. ACKNOWLEDGEMENT
123. REFERENCES
124. Occupational Chronic Obstructive Pulmonary Disease
125. Jaime Szeinuk1 and Rafael E. de la Hoz2,*
126. INTRODUCTION
127. PATHOGENESIS AND PATHOPHYSIOLOGY
128. EPIDEMIOLOGY AND OCCUPATIONAL RISK FACTORS
129. Functional Evidence
130. Imaging Evidence
131. Occupations and Exposures Associated with COPD
132. Occupational Exposure, Cigarette Smoking, and Causal Attribution
133. DIAGNOSIS
134. Additional Diagnostic Evaluation
135. Impairment and Disability Evaluation
136. TREATMENT AND PREVENTION
137. CONCLUSION
138. CONSENT FOR PUBLICATION
139. CONFLICT OF INTEREST
140. ACKNOWLEDGEMENT
141. REFERENCES
142. Work-Related Asthma
143. Kenneth Rosenman1,*
144. INTRODUCTION
145. Case Report
146. PATHOPHYSIOLOGY
147. DIAGNOSIS OF WORK-RELATED ASTHMA
148. TREATMENT
149. HAZARD CONTROL AND DISEASE PREVENTION
150. CONSENT OF PULICATION
151. CONFLICT OF INTEREST
152. ACKNOWLEDGMENTS
153. REFERENCES
154. Acute Respiratory Infections: Diagnosis, Epidemiology, Management, and Prevention
155. Oluwasanmi Oladapo Adenaiye1, Kathleen Marie McPhaul1 and Donald K. Milton1,*
156. INTRODUCTION
157. EPIDEMIOLOGY
158. PATHOPHYSIOLOGY AND TRANSMISSION OF ARI
159. EMERGING VIRUSES 2001 TO 2021
160. WORKPLACES AT RISK FOR ARI
161. PREVENTION AND MANAGEMENT
162. PREVENTION
163. CONTROL MEASURES
164. CONSENT FOR PUBLICATION
165. CONFLICT OF INTEREST
166. ACKNOWLEDGEMENT
167. REFERENCES
168. Malignant Mesothelioma
169. Yasutaka Takinishi1,*, Mika Tanji1, Haining Yang1 and Michele Carbone1
170. EPIDEMIOLOGY
171. Incidence in the United States and Worldwide
172. History and Current Situation of Asbestos Usage and Occupational Exposure
173. Occupational Asbestos Exposure and Mesothelioma
174. Non-occupational Asbestos Exposure
175. Naturally Occurring Asbestos (NOA)
176. MECHANISMS OF ASBESTOS CARCINOGENESIS
177. Carcinogenic Mechanisms of Asbestos
178. BAP1 and MM
179. Other Germline Mutations May Also Predispose to MM
180. DIAGNOSIS OF MM
181. Clinical Presentation
182. Imaging Studies
183. Chest Radiography
184. Computed Tomography
185. Magnetic Resonance Imaging
186. FDG-PET/CT
187. Pathological Features of MM
188. Cytopathological Features
189. Histopathological Features of MM
190. THERAPY
191. Surgery
192. Chemotherapy/Targeted Therapy
193. Radiotherapy
194. Immunotherapy
195. PREVENTION
196. Disclosures
197. CONSENT OF PULICATION
198. CONFLICT OF INTEREST
199. ACKNOWLEDGEMENT
200. REFERENCES
201. Occupational Cancer
202. Ki Moon Bang1,*
203. INTRODUCTION
204. MAGNITUDE OF OCCUPATIONAL CANCER
205. HISTORY OF OCCUPATIONAL CANCER
206. CHARACTERISTICS OF OCCUPATIONAL CANCER
207. Latency Period
208. Dose-Response Relationship
209. Threshold Limit Values
210. Histologic Types
211. Demographic Variables
212. OCCUPATIONAL CARCINOGENS IN HUMAN
213. Asbestos and Respiratory Diseases: Lung cancer, Mesothelioma, Asbestosis
214. Aromatic Amines: Bladder Cancer
215. Alkylating Agents: Lung Cancer and Leukemia
216. Benzene: Myelogenous Leukemia
217. Polycyclic Aromatic Hydrocarbons: Scrotal Cancer and Lung Cancer
218. Vinyl Chloride: Angiosarcoma
219. Metals: Lung Cancer and Skin Cancer
220. Metalworking Fluids: Cancer of the Stomach, Bladder, Pancreas, Larynx, Skin, and Other Sites
221. OCCUPATIONAL CANCER SURVEILLANCE
222. Mortality Data
223. Cancer Survey Data
224. Cancer Registries
225. Type of Occupational Cancer Surveillance Disease-Based Surveillance
226. Exposure-Based Surveillance
227. Medical Screening
228. PRIORITIES FOR OCCUPATIONAL CANCER RESEARCH
229. Asbestos Workers
230. Motor Vehicle Operators
231. Machinists
232. Electric Workers
233. Metal Molders
234. PREVENTION AND CONTROL OF OCCUPATIONAL CANCER
235. CONCLUSION
236. CONSENT FOR PUBLICATION
237. CONFLICT OF INTEREST
238. ACKNOWLEDGEMENT
239. REFERENCES
240. The Role of IARC in Causation of Occupational Diseases: Case Study of the Carcinogenic Evaluation of
241. David F. Goldsmith*
242. INTRODUCTION
243. DETERMINING CAUSE AND EFFECT IN OCCUPATIONAL MEDICINE AND PUBLIC HEALTH
244. Causation in Chronic Diseases
245. Strength of the Association or High Relative Risk (RR)
246. Dose-response (Sometimes Called Exposure-Response) Relationship
247. Consistency of Findings
248. Biological Plausibility, Including Experimental Evidence
249. Temporal Cogency
250. Control of Confounding and Bias
251. Specificity
252. Overall Coherence
253. THE CLASSIFICATION OF CARCINOGENICITY BY THE INTERNATIONAL AGENCY FOR RESEARCH ON CANCER (IARC).
254. THE IARC REVIEWS OF CRYSTALLINE SILICA
255. SILICA HEALTH RESEARCH IN THE WAKE OF IARC ASSESSMENTS
256. POLICY IMPACTS IN THE WAKE OF SILICA’S EVALUATION AS HUMAN CARCINOGEN
257. SILICA DUST ROARS AT WORKERS AND AT OCCUPATIONAL HEALTH PROFESSIONALS
258. SYNTHESIS AND CONCLUSION
259. CONSENT FOR PUBLICATION
260. CONFLICT OF INTEREST
261. ACKNOWLEDGEMENTS
262. REFERENCES
263. Health Effects of Arsenic
264. Rose H. Goldman1,*
265. INTRODUCTION
266. OCCUPATIONAL AND ENVIRONMENTAL EXPOSURES
267. ROUTES OF EXPOSURE, METABOLISM, AND EXCRETION
268. ADVERSE HEALTH EFFECTS
269. Acute Toxicity
270. Chronic and Latent Toxicity
271. ASSESSMENT
272. History
273. Biological Monitoring
274. Environmental/workplace Monitoring
275. TREATMENT
276. PREVENTION
277. CONSENT FOR PUBLICATION
278. CONFLICT OF INTEREST
279. ACKNOWLEDGEMENT
280. REFERENCES
281. Construction: Accessing and Working on Elevated Work Surfaces Safely
282. E.A. McKenzie, Jr.1,*, Mathew G. Hause1 and Thomas G. Bobick1
283. INTRODUCTION
284. EMPLOYMENT IN U.S. – SELECTED DEMOGRAPHICS
285. Construction Fatalities
286. NIOSH FATALITY ASSESSMENT AND CONTROL EVALUATION PROGRAM
287. OSHA FOCUS ENFORCEMENT AREAS AND TRAINING COMPONENTS
288. PLAN Ahead to Get the Job Done Safely
289. PROVIDE the Right Equipment
290. TRAIN Everyone to Use the Equipment Safely
291. PREVENTING CONSTRUCTION FALLS FROM ROOFS, LADDERS, AND SCAFFOLDS
292. Roofs
293. Safety on the Roof
294. Ladders
295. NIOSH Ladder Safety App for Smart Phones
296. Get the Ladder Safety App
297. Scaffolding
298. Mast Climbing Work Platform
299. Aerial Lifts
300. Aerial Lift Hazard Recognition Simulator
301. SUMMARY
302. DISCLAIMER
303. CONSENT FOR PUBLICATION
304. CONFLICT OF INTEREST
305. ACKNOWLEDGMENTS
306. RESOURCES
307. REFERENCES
308. Work-related Musculoskeletal Disorders
309. Ming-Lun Lu1,*, Brian D. Lowe1, Ninica L. Howard2, Alysha R. Meyers1, Robert R. Fox3, Ren G. Dong1 a
310. BACKGROUND
311. Burden of WMSDs
312. WMSD Case Definitions
313. Sources of WMSD Surveillance Data
314. Self-administered Surveys and Questionnaires
315. BLS Annual Survey of Occupational Injuries and Illnesses
316. Workers’ Compensation Claims Data
317. Occupational Health Indicators
318. Syndromic Surveillance
319. Other WMSD Data Sources
320. Selection of Surveillance Data Sources
321. ETIOLOGY OF WMSDS
322. Pathomechanics
323. Skeletal Muscle Contraction Paradigms
324. Risk factors of WMSDs
325. Personal Risk Factors
326. Physical Risk Factors
327. Vibration in the Workplace
328. Workplace psychosocial risk factors
329. Environmental factors
330. ERGONOMIC ASSESSMENT METHODS FOR PHYSICAL RISK FACTORS
331. ERGONOMIC INTERVENTIONS
332. Elimination
333. Substitution
334. Engineering Controls
335. Administrative Controls
336. Personal Protective Equipment
337. Resources for Ergonomic Interventions
338. Intervention Effectiveness—Systematic Reviews/Cochrane Reviews
339. ERGONOMICS GUIDELINES AND STANDARDS
340. International (ISO) and European Standards
341. Working Postures
342. Manual Handling
343. Human Physical Performance
344. Human Vibration Exposures
345. Other Standards and Guidelines on WMSDs Produced by Scientific/ Professional Organizations
346. The Human Factors and Ergonomics Society (HFES)
347. International Ergonomics Association (IEA) Published Guidelines
348. CONCLUDING REMARKS
349. CONSENT FOR PUBLICATION
350. CONFLICT OF INTEREST
351. ACKNOWLEDGMENT
352. REFERENCES
353. Subject Index

People also search for Modern Occupational Diseases Diagnosis Epidemiology Management and Prevention 1st Edition:

    
occupational disease hazards
    
occupational disease means
    
occupational disease insurance
    
occupational diseases a guide to their recognition
    
j diseases

Tags: Ki Moon Bang, Modern Occupational, Epidemiology Management, Prevention